AB

AshHill Biomedical

North America, Ohio, United States, Cincinnati

Description

AshHill is a private investment firm that offers biomedical services.

Investor Profile

AshHill Biomedical has backed more than 3 startups, with 0 new investments in the last 12 months alone. The firm has led 2 rounds, about 67% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Therapeutics.

Stage Focus

  • Series A (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Biopharma
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does AshHill Biomedical frequently co-invest with?

venBio Partners
North America, California, United States, San Francisco
Co-Investments: 1
Atheneos Ventures
North America, California, United States, Santa Clara
Co-Investments: 1
HB
North America, California, United States, Saratoga
Co-Investments: 1
EQT Life Sciences
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 1
Seroba Life Sciences
Europe, Dublin, Ireland, Dublin
Co-Investments: 1
Brandon Capital
Oceania, Victoria, Australia, Melbourne
Co-Investments: 1

Which angels does AshHill Biomedical often collaborate with?

LH
North America, California, United States
Shared Deals: 1

What are some of recent deals done by AshHill Biomedical?

Armetheon

Menlo Park, California, United States

Armetheon is a cardiovascular focused late-clinical stage specialty pharmaceutical company.

BiopharmaBiotechnologyPharmaceutical
Series AAug 28, 2014
Amount Raised: $7,000,000
Heart Metabolics

San Francisco, California, United States

Heart Metabolics is a company based in UK, developing drugs to treat heart failure for hypertrophic cardiomyopathy patients.

BiotechnologyHealth CareTherapeutics
Series AApr 16, 2014
Amount Raised: $20,000,000
Heart Metabolics

San Francisco, California, United States

Heart Metabolics is a company based in UK, developing drugs to treat heart failure for hypertrophic cardiomyopathy patients.

BiotechnologyHealth CareTherapeutics
Series AJan 4, 2013
Amount Raised: $4,000,000